ASEM documentary overview
Official National Advisory Committee on Immunization document (2024) on “Archived: Summary of NACI statement of March 8, 2024: Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid)”. Valid as of March 8, 2024: Summary of the National Advisory Committee on Immunization's recommendations for the updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document